Clinical and Metabolic Parameters in Non-Small Cell Lung Carcinoma and Colorectal Cancer Patients with and without KRAS Mutations

Clinical and Metabolic Parameters in Non-Small Cell Lung Carcinoma and Colorectal Cancer Patients with and without KRAS Mutations

Lung cancer (LC) and colorectal cancer (CRC) are the first and second deadliest types of cancer worldwide. EGFR-based therapy has been used in the treatment of these cancers with variable success. Presence of mutations in the KRAS driver oncogene, possibly induced by environmental factors such as ca...

Full description

Bibliographic Details
Main Authors: Ahmet Yilmaz, Nehad Mohamed, Kara A. Patterson, Yan Tang, Konstantin Shilo, Miguel A. Villalona-Calero, Michael E. Davis, Xiao-Ping Zhou, Wendy Frankel, Gregory A. Otterson, Weiqiang Zhao
Format: Article
Language:English
Published: MDPI AG 2014-08-01
Series:International Journal of Environmental Research and Public Health
Subjects:
KRAS
non-small cell lung carcinoma
colorectal cancer
transition
transversion
Online Access:http://www.mdpi.com/1660-4601/11/9/8645

Internet

http://www.mdpi.com/1660-4601/11/9/8645

Similar Items